Categories Earnings Calls, Health Care

GoHealth Inc. (GOCO) Q4 2020 Earnings Call

GoHealth, Inc.  (NASDAQ: GOCO) Q4 2020 earnings call dated Mar. 08, 2021

Corporate Participants:

Jay Koval — GoHealth, Inc.Vice President of Investor Relations

Clint P. Jones — Co-Founder and Chief Executive Officer

Travis Matthiesen — Chief Financial Officer

Shane Cruz — Chief Operating Officer


Jailendra Singh — Credit Suisse — Analyst

Frank Morgan — RBC — Analyst

Mike Cherny — Bank of America — Analyst

Tobey Sommer — Truist Securities — Analyst

Yaron Kinar — Goldman Sachs — Analyst

Jonathan Yong — Barclays — Analyst

Nathan Abraham — Morgan Stanley — Analyst

Elizabeth Anderson — Evercore ISI — Analyst


To read the full earnings call transcript, click here

Most Popular

Biogen (BIIB) stock research summary | Q3 2021

Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of

Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings

Goldman Sachs (GS) stock research summary | Q3 2021

Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key

Listen On


Add Comment
Viewing Highlight